Spine devicemaker Accelus closed an equity financing round led by Concord Health Partners.
Details about the funding weren’t disclosed in a May 29 news release shared with Becker’s. The capital will support Accelus’ commercial growth.
Accelus also named Bernie Haffey as the new chair for its board of directors. Mr. Haffey has served on Accelus’ board since February 2024 and has more than 20 years of experience in the medtech and healthcare industries.
Accelus’ spine portfolio includes the FlareHawk interbody fusion system, the LineSider spinal system and Toro-L interbody fusion system.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.